endocrine · Mechanism Report
Can hyperprolactinemia cause low testosterone in women?
Elevated prolactin can reduce female testosterone by suppressing gonadotropin signaling and impairing ovarian steroidogenesis.
This is what AI claimed
Hyperprolactinemia can contribute to low testosterone in women by suppressing gonadotropin signaling and impairing ovarian steroidogenesis.
Executive summary
The claim describes that high prolactin inhibits hypothalamic kisspeptin-GnRH activity, leading to decreased LH/FSH secretion and loss of ovarian theca cell stimulation for androgen production. It also notes direct ovarian effects of prolactin that downregulate steroidogenic enzymes, further reducing ovarian-derived testosterone.
Verified conclusion
The hormonal disruption caused by hyperprolactinemia significantly impacts the female reproductive axis, extending beyond the well-known effects on estrogen to influence total androgen production.
Clinical and effectiveness evidence
Hyperprolactinemia is a primary driver of hypogonadotropic hypogonadism. In this state, elevated prolactin levels create a functional deficiency in the hormones that regulate the ovaries.
- Gonadotropin suppression: Extensive research confirms that high prolactin levels disrupt the pulsatile release of Gonadotropin-Releasing Hormone (GnRH). This suppression leads to a subsequent decline in the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary.
- Impact on androgens: In women, approximately 50% of circulating testosterone is derived from the ovaries (either through direct secretion or the peripheral conversion of ovarian androstenedione). Because LH is the primary stimulus for the ovarian theca cells to produce these androgens, the reduction in LH pulses logically results in decreased ovarian testosterone production.
- Clinical presentation: While clinical studies frequently focus on the resulting estrogen deficiency (leading to amenorrhea or bone density loss), the pathway for testosterone reduction is identical. However, some evidence suggests a complex interaction where prolactin may occasionally increase adrenal androgen precursors like DHEA-S, though this rarely compensates for the loss of ovarian output.
Mechanistic explanations
The suppression occurs through a sophisticated neuroendocrine feedback loop:
- Kisspeptin inhibition: Prolactin acts directly on the KNDy (Kisspeptin/Neurokinin B/Dynorphin) neurons in the arcuate nucleus of the hypothalamus. It binds to prolactin receptors (Prlrs) on these neurons, directly inhibiting the expression of kisspeptin. Since kisspeptin is the essential "master switch" for GnRH, its absence halts the entire downstream hormonal cascade.
- Direct ovarian interference: Beyond the brain, prolactin receptors are present on ovarian cells. High levels of prolactin can directly interfere with LH-stimulated androgen synthesis in theca cells and downregulate aromatase (CYP19A1) activity in granulosa cells.
- Dopaminergic activity: Prolactin increases the activity of tuberoinfundibular dopaminergic (TIDA) neurons. While this is a feedback mechanism to inhibit further prolactin release, the increased dopamine can further suppress GnRH pulsatility via D2 receptors.
Bottom line
Hyperprolactinemia is a recognized cause of low testosterone in women. It works by suppressing the hypothalamic kisspeptin-GnRH axis, which removes the LH stimulation necessary for ovarian theca cells to produce testosterone and its precursors.
References
- Acute Suppression of LH Secretion by Prolactin in Female Mice Is Mediated by Kisspeptin Neurons in the Arcuate Nucleus. — academic.oup.com
- What do we know about abnormally low prolactin levels in polycystic ovary syndrome? A narrative review — pmc.ncbi.nlm.nih.gov
- Interactions between prolactin and kisspeptin to control reproduction — pmc.ncbi.nlm.nih.gov
- Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India — semanticscholar.org
- Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. — pmc.ncbi.nlm.nih.gov
- Effects of prolactin on the proliferation and hormone secretion of ovine granulosa cells in vitro — pmc.ncbi.nlm.nih.gov
- Prolactin inhibition of luteinizing hormone-stimulated androgen synthesis in ovarian interstitial cells cultured in defined medium: mechanism of action. — academic.oup.com
- Inhibition of MAPK by Prolactin Signaling through the Short Form of Its Receptor in the Ovary and Decidua — pmc.ncbi.nlm.nih.gov
- Hyperprolactinaemia – a problem in patients from the reproductive period to the menopause — pmc.ncbi.nlm.nih.gov
- Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM) — aem-sbem.com
See a full patient report verified like this
Book a walkthrough